Latest Pharmaceutical News
FDA Accepts NDA Of Onglyza In Combination With Extended Release Metformin
Bristol-Myers Squibb and AstraZeneca have reported that FDA has accepted for review a new drug application (NDA) for an investigational fixed dose combination of Onglyza (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
Published: 18-Mar-2010
Cpex Pharmaceuticals Reveals Preliminary Results Of Nasulin Phase 2a Trial
Cpex Pharmaceuticals (Cpex) has reported preliminary results related to Phase 2a trial of its nasal insulin product Nasulin. The study was designed to evaluate the efficacy and safety of Nasulin versus placebo over a 6-week treatment period in subjects with Type 2 diabetes who were being treated with basal insulin and oral anti-diabetes agents.
Published: 18-Mar-2010
PPD, Southern Research To Jointly Conduct Influenza Vaccine Clinical R&D
Pharmaceutical Product Development (PPD), a global contract research organisation and Southern Research Institute have entered into a collaborative agreement in pandemic and seasonal influenza vaccine research and development to provide clients a full spectrum of influenza vaccine development services by collaborating on client bids and projects.
Published: 18-Mar-2010
Dr Reddy’s Opens Manufacturing Facility For Pharma Grade mPEG Alcohols In Mexico
The Custom Pharmaceutical Services (CPS) business of Dr Reddy’s Laboratories has opened commercial scale manufacturing facility for pharma grade mPEG alcohols at its Cuernavaca facility in Mexico.
Published: 18-Mar-2010
Novartis Pharma Gets EU Approval For Menveo
Novartis Pharma has received European Commission (EC) approval for marketing authorisation of Menveo (Meningococcal Group A, C, W135 and Y conjugate vaccine) in all 27 European member states.
Published: 18-Mar-2010
Reliv Launches GlucAffect In Philippines, Malaysia, Singapore
Reliv International, a nutrition and direct selling company, has introduced a blood-sugar management product GlucAffect, in Singapore, Malaysia and the Philippines.
Published: 17-Mar-2010
Compugen Develops Intracellular Drug Delivery Platform
Compugen has reported the development and validation of Intracellular Drug Delivery (IDD) discovery platform for identification of cell penetrating peptides.
Published: 17-Mar-2010
AtCor Medical Upgrades SphygmoCor Software
AtCor Medical, a developer and marketer of SphygmoCor system that measures central blood pressures and arterial stiffness non-invasively, has launched the latest SphygmoCor software (version 9) at the Annual American College of Cardiology Scientific Session Exposition.
Published: 17-Mar-2010
Trophos Completes Patient Enrolment In Olesoxime Phase 3 Trial
Trophos, a clinical stage pharmaceutical company developing therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, has completed patient enrolment with over 500 patients recruited into the pivotal Phase 3 efficacy study of Olesoxime in amyotrophic lateral sclerosis (ALS).
Published: 17-Mar-2010
Dishman Pharma Receives TGA Approval For API Production
Dishman Pharmaceuticals and Chemicals, a manufacturer of active pharmaceutical ingredients (API), intermediates, quaternary compounds, and crown ethers, has said that its Bavla facilities are approved by Therapeutic Goods Administration (TGA), Department of Health and Ageing of government of Australia, for the production of all APIs, reported MyIris.
Published: 17-Mar-2010
